French genomics software company SeqOne has acquired UK-based Congenica, combining SeqOne's AI-powered next-generation sequencing platform with Congenica's clinical decision support and genome interpretation expertise. The deal creates an integrated offering aimed at accelerating precise diagnoses for rare diseases and advancing personalized cancer therapies. The combined entity will maintain a UK presence, supporting over 160 laboratories in more than 30 countries, and builds on both firms' prior funding rounds and partnerships.